Milestones provides technology, product needs assessment and commercialization planning to organizations to attain auctionable milestones critical to their success.

BUSINESS STRATEGIES PRACTICE

Milestones provides executive-level market intelligence for the commercialization of new markets and technologies for a broad range of purposes, including  comprehensive know-your-market needs assessment; "windows of opportunity" analysis; non-dilutive investment strategies; reimbursement analysis and strategies; informal meetings with the US Food and Drug Administration; and licensing and corporate partner negotiations.

For examples of our work, please visit our business strategies PORTFOLIO ►

GOVERNMENT PRACTICE

Government buyers acquire “off-the-shelf” commercial products through a well-defined acquisition process. But for those novel solutions and pre-commercial products still in early stage development that have the potential to address unmet medical needs, developmental consistency leading to acquisition is not necessarily well envisioned or -practiced. While there are technologies that from a technical perspective qualify for funding through congressionally directed funding programs, e.g., Broad Agency Announcement (BAA) programs or SBIR or NIH, it has been Milestones’ observation that few are evaluated and qualified for commercial potential using business metrics before contract award.

To examine examples of how Milestones has assisted government  staff with the transition of novel technologies into the commercial sector to facilitate acquisition, please visit our government qualifications PORTFOLIO ►

NEWS AND ANALYSIS

To stay on top of broad industry trends, Milestones writes news and commentary of companies, technologies, and issues and is published by a variety of business journals in advanced technology regions throughout North America. PORTFOLIO ►